Our Mission
Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.
After decades of investigation, scientists have unlocked the power of our body's own immune system to fight cancer. This class of treatments—called cancer immunotherapy—enhances a patient's immune system to identify and eliminate cancer cells, anywhere in the body.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization that is dedicated to saving more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.
We fund the most innovative clinical and laboratory research around the world, support the next generation of the field's leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. CRI's programs provide strategic support along the entire pathway of discovery, drug development, and patient support.
Donate Now
Our Impact
Causes We Support
Countries We Serve
United Nations Sustainable Development Goals
The Cancer Research Institute (CRI) is committed to ending cancer deaths globally by advancing lifesaving cancer immunotherapy research around the world. CRI is also committed to reducing inequalities in access to health care information and treatment by providing educational programming and resources in both English and Spanish, and provides dedicated funding for research scientists from communities that are underrepresented in academic research.
